A major breakthrough in cancer research is arising with the use of nanobodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently disabled in several forms of malignancies, resulting https://tripsbookmarks.com/story21978742/vhh-fragments-reactivate-tumor-suppressor-p53-a-new-hope-for-tumor-therapy